Phase II Trial of Adjuvant Oral Thalidomide Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Disease from Colorectal/Appendiceal Cancer

PURPOSE: This phase II single-institution trial of adjuvant thalidomide after cytoreductive surgery (CS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with appendiceal and colorectal malignancies sought to detect an improvement in progression-free survival (PFS) from 7 to 12 mon...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Shen, Perry, Thomas, Christopher R., Fenstermaker, Joyce, Aklilu, Mebea, McCoy, Thomas P., Levine, Edward A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2014
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4108576/
https://ncbi.nlm.nih.gov/pubmed/24452995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12029-014-9578-y
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items